Join the 200th Anniversary Celebration

Original Article

Brief Report

Patient-to-Patient Transmission of Hepatitis C Virus during Colonoscopy

Jean-Pierre Bronowicki, M.D., Véronique Venard, Pharm.D., Christine Botté, M.D., Nathalie Monhoven, Ph.D., Isabelle Gastin, M.D., Laurence Choné, M.D., Hervé Hudziak, M.D., Bertrand Rhin, M.D., Christophe Delanoë, M.D., Alain LeFaou, M.D., Marc-André Bigard, M.D., and Pierre Gaucher, M.D.

N Engl J Med 1997; 337:237-240July 24, 1997

Article

Invasive diagnostic or therapeutic procedures may be a route for the transmission of the hepatitis C virus (HCV).1-5 In a study of patients in a gastrointestinal-disease unit, endoscopic biopsies were found to be an independent risk factor for HCV infection.6 We report the transmission of HCV during colonoscopy from a person known to have HCV infection to two other patients. The patient-to-patient transmission was ascertained by sequencing the nucleotides in the various HCV isolates.

Case Report

A 55-year-old man (Patient 1) and his 54-year-old wife (Patient 2) were referred in October 1995. In June 1995, both had had hepatitis-like illnesses, with nausea, abdominal pain, and conjunctival icterus. They had elevated serum alanine aminotransferase levels and tested positive for HCV antibodies by third-generation assays (Ortho Diagnostic Systems, Roissy en France, France, and Pasteur Diagnostique, Marnes-la-Coquette, France). Both had been regular blood donors for 20 years; they had had normal liver-enzyme levels and negative HCV serologic tests at the time of their most recent blood donations, in January 1995. They had not had blood transfusions, and there was no evidence of intravenous drug use. However, both patients had family histories of colon cancer, and both had undergone colonoscopy on March 16, 1995. Their serum alanine aminotransferase levels one week earlier were normal. Neither patient had previously undergone endoscopy in the same unit.

Liver biopsies were performed in both patients in November 1995, and the histologic activity was measured by the Knodell score.7 The biopsies revealed chronic hepatitis, minimal in Patient 2 and moderate in Patient 1 (Knodell scores, 3 and 9, respectively). No fibrosis was found in either biopsy specimen. The results of serologic tests for HCV were confirmed by third-generation enzyme immunoassays (Ortho Diagnostic Systems and Abbott Diagnostic Division, Rungis, France). Both patients tested negative for hepatitis B virus (HBV) and human immunodeficiency virus (HIV) types 1 and 2.

Methods

The temporal relation between HCV positivity and colonoscopy in the two patients led us to suspect a nosocomial infection (Figure 1Figure 1Clinical, Biochemical, Serologic, and Molecular Profiles of Patients 1 and 2.). We investigated whether any HCV-positive patients had undergone colonoscopy in the clinic on the same day as our patients and whether any staff member performing endoscopy was HCV-positive. By genotyping and nucleotide sequencing of the HCV genome, we compared the virus isolated from our patients with that isolated from a patient known to be HCV-positive. We studied the procedures used for anesthesia and colonoscopy, in particular the techniques used in cleaning and disinfecting the endoscopes, to try to determine a possible route of infection.

All the staff members involved in performing endoscopy (one gastroenterologist, one anesthetist, one nurse, and one nurse's aide) tested negative for HCV serology by third-generation assays. Only three colonoscopies were performed on March 16, 1995. The first involved a 42-year-old woman (Patient 3) with a history of polypectomy. She was known to have been HCV-positive for one year, but she had not been treated because she had chronic depression. In November 1995, her serum alanine aminotransferase level was 43 IU per liter (normal level, <40). Serologic tests were positive for HCV and negative for HBV and HIV.

Detection and Titration of HCV RNA

Serum samples from Patients 1 and 2 collected in January 1995 at the time of blood donation and frozen at -80°C and serum samples obtained from Patients 1, 2, and 3 in October and November 1995 were tested for HCV RNA by a reverse-transcription polymerase chain reaction (PCR) with primers from the highly conserved 5' noncoding region of the HCV genome (Table 1Table 1Nucleotide Sequences and Positions of HCV Primers.). Briefly, RNA was extracted from 100 μl of serum with use of the method described by Chomczynski and Sacchi.9 RNA samples were heated for 10 minutes at 70°C and then incubated for 60 minutes at 37°C in a reaction mixture containing reverse-transcription buffer, 10 mM dithiothreitol, 1 mM of each deoxynucleotide triphosphate, 10 U of RNAsin (Life Technologies, Cergy Pontoise, France), 200 U of reverse transcriptase of Moloney murine leukemia virus (Life Technologies), and 0.4 mM outer antisense primer. The samples were then heated to 100°C for 10 minutes. Distilled water, extraction buffer, and HCV-negative serum samples were used as negative controls. Serum positive for HCV RNA served as a positive control. The complementary DNA (cDNA) was amplified by a nested PCR.10 The first PCR was performed in a 50-μl reaction mixture containing Taq polymerase buffer, 1 mM of each deoxynucleotide triphosphate, 1.5 mM magnesium chloride, 1 mM of each outer primer, 1 U of Taq polymerase (Life Technologies), and 5 μl of cDNA. There were 35 PCR cycles consisting of denaturation at 95°C for one minute, annealing at 55°C for one minute, and extension at 72°C for one minute.

The second PCR reaction was performed as described above for 25 cycles, with 5 μl of the first PCR product and the inner primers. The PCR products were subjected to electrophoresis in 2 percent agarose gels, stained with ethidium bromide, and visualized under ultraviolet light. The expected size of the amplification product was 190 bp.

HCV RNA was measured in serum by a branched-chain DNA assay (Quantiplex bDNA 2.00, Chiron Diagnostics Europe, Cergy Pontoise, France) in accordance with the instructions of the manufacturer.

HCV Genotyping and Nucleotide Sequencing

HCV genotyping was performed by a line-probe assay according to the instructions of the manufacturer (Innogenetics, Antwerp, Belgium). This assay is based on variations in the 5' untranslated regions of the various HCV genotypes. In the line-probe assay, type-specific probes are tagged with poly(T) tails by terminal deoxynucleotidyl transferase and attached to nitrocellulose membranes. Amplified products labeled with biotin are hybridized in reverse to the probes on the nitrocellulose strip. The biotin group is incorporated by using a 5'-biotinylated primer during the amplification. The labeled product obtained from the 5' untranslated region hybridizes with the probe that has a perfect match of sequences. After hybridization, streptavidin labeled with alkaline phosphatase is added and bound to any biotinylated hybrid formed. This technique allows the six major types of HCV and their most common subtypes to be detected.

To study the HCV sequences in the three patients, we performed a nested reverse-transcription PCR in nonstructural region 3 (NS3) with the patients' serum samples (using the primers described in Table 1). The NS3 region probably codes for a protease and helicase. Serum positive for HCV genotype 1b was used as a positive control, and serum negative for HCV RNA was used as a negative control. The NS3 region was chosen for the analysis of sequencing because the 5' noncoding and core regions appear to be quite conserved among the various types of HCV, whereas the putative envelope regions are highly variable even among examples of the same HCV subtype.11

To check the size of the amplification products, the PCR products were subjected to electrophoresis in 2 percent agarose gels and visualized with ethidium bromide staining (expected size, 186 bp). Each sample was tested in triplicate. The PCR products were gently separated from the agarose gel, purified by separation with a minicolumn (Wizard A7170, Promega, Madison, Wis.), and eluted in 50 μl of distilled water. The total yield of DNA was determined by spectrophotometry; 100 ng of purified DNA product was used in the cycle-sequencing reactions (Prism 401388, Applied Biosystems, Foster City, Calif.), which were performed according to the instructions of the manufacturer. The sequencing products were analyzed with a DNA-sequencing system (Model 373 A, Applied Biosystems). At least two sequencing reactions were performed with each sample, with the appropriate sense and antisense primers (Table 1). The sequences were aligned with use of the Clustal V program, which is widely employed to study the alignment of multiple sequences.12 This software is marketed under various names by various manufacturers. We used Assemblylign (Kodak International Biotechnologies, New Haven, Conn.). The nucleotide alignments were compared among the three patients, the control serum positive for HCV genotype 1b, and the published sequence of HCV genotype 1b.8,13

Results

Detection and Quantitation of HCV RNA

The serum samples collected from Patients 1 and 2 in January 1995 tested negative for HCV RNA, whereas those obtained in October and November 1995 tested positive. The level of viremia of Patient 3 in November 1995 was 3.5 million genome equivalents per milliliter.

Genotyping and Sequencing of HCV

All three patients were infected with HCV genotype 1b. Nucleotide sequencing of the NS3 region showed that the three patients were all infected with the same isolate, because there was 100 percent nucleotide homology among the three clones. The degree of homology between the nucleotides in the NS3 region, the control serum positive for HCV genotype 1b, and the published sequences of HCV-BK8 and HCV-J13 genotype 1b isolates ranged from 86.9 percent to 89 percent. The degree of homology in the amino acid sequences deduced from the nucleotide sequences ranged from 89.6 to 96 percent (Figure 2Figure 2Nucleotide Sequence of the HCV NS3 Gene Region in the Three Patients Who Underwent Colonoscopy on March 16, 1995, as Compared with the Sequence in Control Serum Positive for HCV Genotype 1b and Two Published Sequences of That Genotype.).

Procedures Used for Colonoscopy, Disinfection, and Anesthesia

Patient 3 underwent colonoscopy from 10:10 to 10:30 a.m., and Patient 2 underwent the procedure from 11:00 to 11:30 a.m. Multiple biopsy specimens were obtained from both patients, because micropolyps were found. Patient 1 had a polypectomy between noon and 12:30 p.m. in which a diathermic loop was used. The same colonoscope (Olympus, Tokyo, Japan) was used throughout all three procedures. The biopsy specimens from Patients 2 and 3 were obtained with the same forceps.

After each procedure, the colonoscope was immediately immersed for 10 minutes in water containing detergent and washed on the outside with disposable swabs. The air, water, and biopsy-suction channels were washed with the same detergent as the colonoscope, with an all-channel irrigator (Olympus). After being rinsed with water, the endoscope and all the internal channels were soaked for five minutes in 2 percent glutaraldehyde. Rinsing in water and drying with compressed air followed.

During the procedures, the biopsy-suction channel was never thoroughly cleaned with an appropriate brush. A consensus report on endoscope disinfection14 has emphasized that the brush used in cleaning should be appropriate for the instrument and channel size. This mechanical cleaning is used to remove residual tissue, the presence of which may contribute to the failure of the cleaning and disinfection procedures. In interviews, nurses stated that this cleaning step was never performed in the clinic. After each procedure, the biopsy forceps and the diathermic loop were cleaned mechanically in detergent and in glutaraldehyde, but they were not autoclaved.

The same procedure for anesthesia was used in each patient. An intravenous line was inserted, and anesthesia was induced by injecting fentanyl and midazolam directly into the line. Anesthesia was maintained by injecting propofol continuously into the intravenous line with an electric syringe. The intravenous tubing was changed after each patient's procedure. Because Patient 3 was known to be HCV-positive, the intravenous line and the syringes used to inject the fentanyl, midazolam, and propofol were thrown away after that patient's procedure, which was the first of the three. During the interval between the procedures in Patient 2 and Patient 1, the intravenous lines and the needles were changed, but the same syringes of fentanyl, midazolam, and propofol were used.

Discussion

The timing of the events and the molecular characterization of the various HCV isolates provide evidence that HCV was transmitted during colonoscopy. There are few documented cases of viral transmission during endoscopy.15 One case of transmission of HBV in this manner has been reported.16 Acute hepatitis C was reported in a patient 10 weeks after the patient underwent retrograde cholangiography with sphincterotomy; no genotyping or nucleotide sequencing was performed, and HCV could not be proved to have been transmitted during the endoscopy.17 In both these cases, the disinfection procedure used was considered inadequate.

We suggest that during the disinfection of the colonoscope after the procedures in the patients we describe, two recommendations on endoscopic disinfection made by the American Society for Gastrointestinal Endoscopy14 and the British Society of Gastroenterology18 and the working party of the World Congresses of Gastroenterology19 were not followed. From our investigation it appeared that the biopsy-suction channel was never cleaned with a brush and that the accessories that breach the mucosa, such as the biopsy forceps and the diathermic loop, were not autoclaved after each use. Recently, the effectiveness of manual cleaning and disinfection in preventing the transmission of HCV was assessed by testing the effluent from the endoscope biopsy channel by reverse-transcription PCR for the presence of HCV RNA.20 That study involved 39 patients with chronic hepatitis C who underwent gastroscopy with biopsy. Sterile water was flushed through the biopsy channel immediately after the removal of the endoscope, after cleaning with a detergent solution, and after a final disinfection with glutaraldehyde. HCV RNA was found in two cases before the cleaning with a detergent, but in every case the water flushed through the biopsy channel after the cleaning step and after the disinfection with glutaraldehyde was negative for HCV RNA.20 These findings confirm that the disinfection procedure is effective when all the recommendations are followed.

Other studies assessing the degree of adherence to guidelines for the cleaning and disinfection of gastrointestinal endoscopes have pointed out the high rate of inadequate disinfection procedures (30 to 100 percent).14 Failure to follow the recommended procedures can have an important role in the endoscopic transmission of microorganisms.

The possibility that HCV was transmitted because of inadequate procedures in the use of anesthesia should also be considered. We believe this route of transmission is less likely, because the intravenous tubing and all the syringes containing the anesthetic drugs were changed after the first colonoscopy, in which the patient evaluated was known to be HCV-positive. However, inadequate procedures were followed during the other two procedures. Only the intravenous tubing and the needles were changed between the endoscopies of Patients 2 and 1. The anesthetist stated that he discarded syringes only after they were used in a patient known to be infected. To justify this approach, he said that he systematically used a check valve to avoid the backflow of blood into the syringe. However, other studies have shown that the rate at which blood contaminates the intravenous tubing used for anesthesia is substantial (0.3 to 3.3 percent of cases).21-23 The presence of a check valve and the changing of the needle do not affect the rate at which intravenous lines and syringes become contaminated — a point that should be emphasized, because multidose vials are very commonly used in anesthesia.21-23 Moreover, because the assessment of risk factors is not a reliable predictor of which patients have chronic viral infection, the practice of following strict procedures for anesthesia only in patients with known infections has little rationale and should be abandoned. The standard of care should be to use equipment and ampules only once.

We are indebted to Dr. M.P. Mahoney for his help in preparing this article.

Source Information

From the Service d'Hépato-Gastroentérologie (J.-P.B., L.C., H.H., C.D., M.-A.B., P.G.), the Laboratoire de Microbiologie (V.V., B.R., A.L.), the Etablissement de Transfusion Sanguine (C.B.), the Laboratoire Commun de Biologie Moléculaire (N.M.), and the Laboratoire de Pathologie Cellulaire et Moléculaire en Nutrition (J.-P.B., I.G., M.-A.B., P.G.), Faculté de Médecine et Centre Hospitalier Universitaire de Nancy, Vandoeuvre, France.

Address reprint requests to Dr. Bronowicki at the Service d'Hépato-Gastroentérologie, CHU de Nancy, 54500 Vandoeuvre, France.

References

References

  1. 1

    Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334:1691-1696
    Full Text | Web of Science | Medline

  2. 2

    Kiyosawa K, Tanaka E, Sodeyama T, et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. Gastroenterology 1994;106:1596-1602
    Web of Science | Medline

  3. 3

    Allander T, Gruber A, Naghavi M, et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995;345:603-607
    CrossRef | Web of Science | Medline

  4. 4

    Allander T, Medin C, Jacobson SH, Grillner L, Persson MAA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994;43:415-419
    CrossRef | Web of Science | Medline

  5. 5

    Esteban JI, Gomez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996;334:555-560
    Full Text | Web of Science | Medline

  6. 6

    Andrieu J, Barny S, Colardelle P, et al. Prévalence et facteurs de risque de l'infection par le virus de l'hépatite C dans une population hospitalisée en Gastroentérologie: rôle des biopsies per-endoscopiques. Gastroenterol Clin Biol 1995;19:340-345
    Web of Science | Medline

  7. 7

    Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435
    CrossRef | Web of Science | Medline

  8. 8

    Takamizawa A, Mori C, Fuke I, et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991;65:1105-1113
    Web of Science | Medline

  9. 9

    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159
    CrossRef | Web of Science | Medline

  10. 10

    Paterlini P, Driss F, Nalpas B, et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 1993;17:20-29
    CrossRef | Web of Science | Medline

  11. 11

    Simmonds P. Variability of hepatitis C virus. Hepatology 1995;21:570-583
    CrossRef | Web of Science | Medline

  12. 12

    Higgens DG, Bleasby AJ, Fuchs R. CLUSTAL V: improved software for multiple sequence alignments. Comput Appl Biosci 1992;8:189-191
    Medline

  13. 13

    Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A 1990;87:9524-9528
    CrossRef | Web of Science | Medline

  14. 14

    Infection control during gastrointestinal endoscopy: guidelines for clinical applicationGastrointest Endosc 1988;34:Suppl:37S-40S
    Web of Science | Medline

  15. 15

    Spach DH, Silverstein FE, Stamm WE. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med 1993;118:117-128
    Web of Science | Medline

  16. 16

    Birnie GG, Quigley EM, Clements GB, Follett EA, Watkinson G. Endoscopic transmission of hepatitis B virus. Gut 1983;24:171-174
    CrossRef | Web of Science | Medline

  17. 17

    Tennenbaum R, Colardelle P, Chochon M, Maisonneuve P, Jean F, Andrieu J. Hépatite C après cholangiographie rétrograde. Gastroenterol Clin Biol 1993;17:763-764
    Web of Science | Medline

  18. 18

    Cleaning and disinfection of equipment for gastrointestinal flexible endoscopy: interim recommendations of a Working Party of the British Society of Gastroenterology. Gut 1988;29:1134-1151
    CrossRef | Web of Science | Medline

  19. 19

    Axon AT. Disinfection and endoscopy: summary and recommendations: working party report to the World Congresses of Gastroenterology, Sydney 1990. J Gastroenterol Hepatol 1991;6:23-24
    CrossRef | Web of Science | Medline

  20. 20

    Rey J-F, Halfon P, Feryn J-M, Khiri H, Masseyeff M-F, Ouzan D. Risque de transmission du virus de l'hépatite C par l'endoscopie digestive. Gastroenterol Clin Biol 1995;19:346-349
    Web of Science | Medline

  21. 21

    Trepanier CA, Lessard MR, Brochu JG, Denault PH. Risk of cross-infection related to the multiple use of disposable syringes. Can J Anaesth 1990;37:156-159
    CrossRef | Web of Science | Medline

  22. 22

    Parlow JL. Blood contamination of drug syringes used in anaesthesia. Can J Anaesth 1989;36:Suppl:S61-S62

  23. 23

    Kempen PM. Contamination of syringes. Can J Anaesth 1990;37:730-731

Citing Articles (145)

Citing Articles

  1. 1

    Prasoon Jain, Atul C. Mehta. 2012. Infection Control and Radiation Safety in the Bronchoscopy Suite. , 6-31.
    CrossRef

  2. 2

    Jai Hoon Yoon, Byung Chul Yoon, Hang Lak Lee, Jun Kyu Lee, Yong-Tae Kim, Dong Ho Lee, Il Ju Choi, Don Haeng Lee, Dong Hee Kim. (2011) Comparison of Sterilization of Reusable Endoscopic Biopsy Forceps by Autoclaving and Ethylene Oxide Gas. Digestive Diseases and Sciences
    CrossRef

  3. 3

    Louise-Marie Dembry, Carlos Torres-Viera. 2011. Infection Control Basics. , 39-54.
    CrossRef

  4. 4

    Hiren Pokharna, Anne Y. Chen. 2011. The Hospital and Ambulatory Care Environment. , 1-21.
    CrossRef

  5. 5

    Bret T. Petersen, Jennifer Chennat, Jonathan Cohen, Peter B. Cotton, David A. Greenwald, Thomas E. Kowalski, Mary L. Krinsky, Walter G. Park, Irving M. Pike, Joseph Romagnuolo, William A. Rutala. (2011) Multisociety guideline on reprocessing flexible gastrointestinal endoscopes: 2011. Gastrointestinal Endoscopy 73:6, 1075-1084
    CrossRef

  6. 6

    Bret T. Petersen, Jennifer Chennat, Jonathan Cohen, Peter B. Cotton, David A. Greenwald, Thomas E. Kowalski, Mary L. Krinsky, Walter G. Park, Irving M. Pike, Joseph Romagnuolo, William A. Rutala. (2011) Multisociety Guideline on Reprocessing Flexible GI Endoscopes: 2011. Infection Control and Hospital Epidemiology 32:6, 527-537
    CrossRef

  7. 7

    William A. Rutala, David J. Weber. (2011) Sterilization, High-Level Disinfection, and Environmental Cleaning. Infectious Disease Clinics of North America 25:1, 45-76
    CrossRef

  8. 8

    Lindy Forte, Cynthia Shum. (2011) Comparative cost-efficiency of the EVOTECH endoscope cleaner and reprocessor versus manual cleaning plus automated endoscope reprocessing in a real-world Canadian hospital endoscopy setting. BMC Gastroenterology 11:1, 105
    CrossRef

  9. 9

    Sun Young Kim, Hong Sik Lee, Jong Jin Hyun, Min Ho Seo, Sun Young Yim, Ha Young Oh, Hye Sook Kim, Bora Keum, Yeon Seok Seo, Yong Sik Kim, Yoon Tae Jeen, Hoon Jai Chun, Soon Ho Um, Chang Duck Kim, Ho Sang Ryu. (2011) Comparison on the Efficacy of Disinfectants Used in Automated Endoscope Reprocessors: PHMB-DBAC versus Orthophthalaldehyde. Clinical Endoscopy 44:2, 109
    CrossRef

  10. 10

    Ana Ignjatovic, Brian Saunders. 2010. Complications of Colonoscopy. , 58-63.
    CrossRef

  11. 11

    Ju Dong Yang, Lewis R. Roberts. (2010) Hepatocellular carcinoma: a global view. Nature Reviews Gastroenterology & Hepatology 7:8, 448-458
    CrossRef

  12. 12

    Bruce Gutelius, Joseph F. Perz, Monica M. Parker, Renee Hallack, Rachel Stricof, Ernest J. Clement, Yulin Lin, Guo-Liang Xia, Amado Punsalang, Antonella Eramo, Marci Layton, Sharon Balter. (2010) Multiple Clusters of Hepatitis Virus Infections Associated With Anesthesia for Outpatient Endoscopy Procedures. Gastroenterology 139:1, 163-170
    CrossRef

  13. 13

    Lawrence F. Muscarella. (2010) The Study of a Contaminated Colonoscope. Clinical Gastroenterology and Hepatology 8:7, 577-580.e1
    CrossRef

  14. 14

    Carmi Santos, Steven K. Herrine. (2010) Making the Best of a Bad Situation: Early Chronic Nosocomial HCV infection. Digestive Diseases and Sciences 55:6, 1509-1511
    CrossRef

  15. 15

    Nazish Bostan, Tariq Mahmood. (2010) An overview about hepatitis C: A devastating virus. Critical Reviews in Microbiology 36:2, 91-133
    CrossRef

  16. 16

    Gil Rodríguez-Caravaca, María Concepción Villar-del-Campo, María Luisa Casas-Losada, Fernando Cava-Valenciano, Ángel Gil-de-Miguel. (2010) Brote de hepatitis C en una unidad de oncología. Enfermedades Infecciosas y Microbiología Clínica 28:4, 233-235
    CrossRef

  17. 17

    Scott D. Holmberg. (2010) Molecular Epidemiology of Health Care–Associated Transmission of Hepatitis B and C Viruses. Clinics in Liver Disease 14:1, 37-48
    CrossRef

  18. 18

    Angela Michelin, David K. Henderson. (2010) Infection Control Guidelines for Prevention of Health Care–Associated Transmission of Hepatitis B and C Viruses. Clinics in Liver Disease 14:1, 119-136
    CrossRef

  19. 19

    Hao Wu, Bo Shen. (2010) Health Care–Associated Transmission of Hepatitis B and C Viruses in Endoscopy Units. Clinics in Liver Disease 14:1, 61-68
    CrossRef

  20. 20

    Thierry Morin, Alexandre Pariente, Pierre Lahmek, Christian Rabaud, Christine Silvain, Jean François Cadranel. (2010) Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort. European Journal of Gastroenterology & Hepatology 22:2, 157-166
    CrossRef

  21. 21

    Fernando González-Candelas. 2010. Molecular Phylogenetic Analyses in Court Trials. .
    CrossRef

  22. 22

    Keiji Fujihara, Akihisa Togawa, Masashi Ogami, Shin Takei, Yorihiko Ikeda, Muneki Hotomi, Shinji Tamura, Noboru Yamanaka. (2010) Flexible Nasopharyngeal Fiberscope Cleaning and Sterilization. Practica Oto-Rhino-Laryngologica 103:9, 873-879
    CrossRef

  23. 23

    M. Eterpi, G. McDonnell, V. Thomas. (2009) Disinfection efficacy against parvoviruses compared with reference viruses. Journal of Hospital Infection 73:1, 64-70
    CrossRef

  24. 24

    Takayuki Toda, Takehiro Mitsui, Yukie Tsukamoto, Takeshi Ebara, Kazuo Masuko, Masaharu Takahashi, Hiroaki Okamoto. (2009) NO EVIDENCE FOR PATIENT-TO-PATIENT TRANSMISSION OF HEPATITIS C VIRUS DURING UPPER GASTROINTESTINAL ENDOSCOPY: MOLECULAR STUDIES ON THREE ACUTE HEPATITIS C PATIENTS. Digestive Endoscopy 21:3, 147-153
    CrossRef

  25. 25

    R.S. Ross, S. Viazov, Y.E. Khudyakov, G.L. Xia, Y. Lin, H. Holzmann, C. Sebesta, M. Roggendorf, O. Janata. (2009) Transmission of hepatitis C virus in an orthopedic hospital ward. Journal of Medical Virology 81:2, 249-257
    CrossRef

  26. 26

    Priti R. Patel, Arjun Srinivasan, Joseph F. Perz. (2008) Developing a broader approach to management of infection control breaches in health care settings. American Journal of Infection Control 36:10, 685-690
    CrossRef

  27. 27

    G. Spinzi, R. Fasoli, R. Centenaro, G. Minoli. (2008) Reprocessing in digestive endoscopy units in Lombardy: Results of a regional survey. Digestive and Liver Disease 40:11, 890-896
    CrossRef

  28. 28

    Gregory J. Dore, Paul S. Haber. (2008) Tell me it ain't so: Patient-to-patient transmission of hepatitis C in an endoscopy clinic. Hepatology 48:4, 1333-1335
    CrossRef

  29. 29

    Emmanuelle Girou, Stéphane Chevaliez, Dominique Challine, Michaël Thiessart, Yoann Morice, Philippe Lesprit, Latifa Tkoub‐Scheirlinck, Sophan Soing‐Altrach, Florence Cizeau, Celine Cavin, Martine André, Djamel Dahmanne, Philippe Lang, Jean‐Michel Pawlotsky. (2008) Determinant Roles of Environmental Contamination and Noncompliance with Standard Precautions in the Risk of Hepatitis C Virus Transmission in a Hemodialysis Unit. Clinical Infectious Diseases 47:5, 627-633
    CrossRef

  30. 30

    Jean-François Cadranel, Vincent Di Martino, Guy Lambrey, Catherine Mourlhon, Bernard Nalet, Marie-Laure Anciaux, Christian Richard, Jean-Paul Bigué, Jean-Noël Barjon, Christian Bories, Jean-Claude Barbare, Chantal Halimi, Olivier Ribière, Claude Eugène, Arnaud Pauwels, Sandrine Jeanne, Laurence Donato, Patrice Dumouchel, Alexandre Pariente, Gilles Duverlie, Bruno Devergie, Sylvie Arlot, Dominique Capron. (2008) Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study. European Journal of Gastroenterology & Hepatology 20:9, 829-836
    CrossRef

  31. 31

    R. Howie, M.J. Alfa, K. Coombs. (2008) Survival of enveloped and non-enveloped viruses on surfaces compared with other micro-organisms and impact of suboptimal disinfectant exposure. Journal of Hospital Infection 69:4, 368-376
    CrossRef

  32. 32

    C. BROUARD, P. PRADAT, E. DELAROCQUE-ASTAGNEAU, C. SILVAIN. (2008) Epidemiological characteristics and medical follow-up of 61 patients with acute hepatitis C identified through the hepatitis C surveillance system in France. Epidemiology and Infection 136:07,
    CrossRef

  33. 33

    Subhas Banerjee, Bo Shen, Douglas B. Nelson, David R. Lichtenstein, Todd H. Baron, Michelle A. Anderson, Jason A. Dominitz, S. Ian Gan, M. Edwyn Harrison, Steven O. Ikenberry, Sanjay B. Jagannath, Robert D. Fanelli, Ken Lee, Trina van Guilder, Leslie E. Stewart. (2008) Infection control during GI endoscopy. Gastrointestinal Endoscopy 67:6, 781-790
    CrossRef

  34. 34

    Muhammad IDREES, Amreek LAL, Muhammad NASEEM, Muhammad KHALID. (2008) High prevalence of hepatitis C virus infection in the largest province of Pakistan. Journal of Digestive Diseases 9:2, 95-103
    CrossRef

  35. 35

    Charles G. Roberts, Harriet B. Chan-Myers, Martin S. Favero. (2008) Virucidal activity of ortho-phthalaldehyde solutions against hepatitis B and C viruses. American Journal of Infection Control 36:3, 223-226
    CrossRef

  36. 36

    Fernanda Lessa, Sangwoo Tak, Shannon R. DeVader, Rekha Goswami, Mary Anderson, Ian Williams, Kathleen F. Gensheimer, Arjun Srinivasan. (2008) Risk of Infections Associated with Improperly Reprocessed Transrectal Ultrasound–Guided Prostate Biopsy Equipment. Infection Control and Hospital Epidemiology 29:4, 289-293
    CrossRef

  37. 37

    Ch. Boustiere, B. Napoleon, P. Delasalle, P. Coulom. (2008) Digestive endoscopies are not a risk factor for transmission of virus C. Journal of Viral Hepatitis 15:2, 155-155
    CrossRef

  38. 38

    Miriam J. Alter. (2008) Healthcare should not be a vehicle for transmission of hepatitis C virus. Journal of Hepatology 48:1, 2-4
    CrossRef

  39. 39

    Josep Quer, Juan-Ignacio Esteban, Josep-Maria Sánchez, Teresa Otero, Cristina Rius, Mar Coll, Maria Cubero, Gina Moreno, Antonio Gonzalez, Josep Vaque, Rafael Esteban, Magda Campins, Helena Pañella, Jaume Guardia, Maria Martell. (2008) Nosocomial transmission of hepatitis C virus during contrast-enhanced computed tomography scanning. European Journal of Gastroenterology & Hepatology 20:1, 73-78
    CrossRef

  40. 40

    Juan I. Esteban, Silvia Sauleda, Josep Quer. (2008) The changing epidemiology of hepatitis C virus infection in Europe. Journal of Hepatology 48:1, 148-162
    CrossRef

  41. 41

    Eva Martínez-Bauer, Xavier Forns, Mercé Armelles, Ramon Planas, Ricard Solà, Mercé Vergara, Silvia Fàbregas, Roser Vega, Javier Salmerón, Moisés Diago, Jose María Sánchez-Tapias, Miquel Bruguera. (2008) Hospital admission is a relevant source of hepatitis C virus acquisition in Spain. Journal of Hepatology 48:1, 20-27
    CrossRef

  42. 42

    Jane D. Siegel, Emily Rhinehart, Marguerite Jackson, Linda Chiarello. (2007) 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. American Journal of Infection Control 35:10, S65-S164
    CrossRef

  43. 43

    Chia C. Wang, Elizabeth Krantz, Jared Klarquist, Meighan Krows, Lanamarie McBride, Edward P. Scott, Thomas Shaw‐Stiffel, Scott J. Weston, Hanne Thiede, Anna Wald, Hugo R. Rosen. (2007) Acute Hepatitis C in a Contemporary US Cohort: Modes of Acquisition and Factors Influencing Viral Clearance. The Journal of Infectious Diseases 196:10, 1474-1482
    CrossRef

  44. 44

    David Greenwald. (2007) Risks of Reprocessing Endoscopes and Reusable Instruments. Techniques in Gastrointestinal Endoscopy 9:4, 233-235
    CrossRef

  45. 45

    Elisabeth Delarocque-Astagneau, Josiane Pillonel, Henriette De Valk, Alberto Perra, Syria Laperche, Jean-Claude Desenclos. (2007) An Incident Case–Control Study of Modes of Hepatitis C Virus Transmission in France. Annals of Epidemiology 17:10, 755-762
    CrossRef

  46. 46

    S. Laperche, J. Pillonel. (2007) Influence of epidemiological factors on blood transfusion. ISBT Science Series 2:1, 78-84
    CrossRef

  47. 47

    U. R. Goessler, C. Dömming, H. Schmidt, K. Hörmann, N. Stasche. (2007) Erfahrungen in der hygienischen Aufbereitung starrer optischer Instrumente mit Reinigungs-Desinfektions-Geräten in Bezug auf Praktikabilität im klinischen Alltag. HNO 55:S01, E23-E28
    CrossRef

  48. 48

    Nabiel N. Mikhail, David L. Lewis, Nabiel Omar, Hossam Taha, Amal El-Badawy, Naglaa Abdel-Mawgoud, Mohamed Abdel-Hamid, George T. Strickland. (2007) Prospective study of cross-infection from upper-GI endoscopy in a hepatitis C–prevalent population. Gastrointestinal Endoscopy 65:4, 584-588
    CrossRef

  49. 49

    Lev Ginzburg, David Greenwald, Jonathan Cohen. (2007) Complications of Endoscopy. Gastrointestinal Endoscopy Clinics of North America 17:2, 405-432
    CrossRef

  50. 50

    Santos Santolaria, Julio Ducons, Josep Maria Bordas. (2007) Limpieza y desinfección en endoscopia digestiva. Gastroenterología y Hepatología 30:1, 25-35
    CrossRef

  51. 51

    M. Karmochkine, F. Carrat, O. Dos Santos, P. Cacoub, G. Raguin, . (2006) A case?control study of risk factors for hepatitis C infection in patients with unexplained routes of infection. Journal of Viral Hepatitis 13:11, 775-782
    CrossRef

  52. 52

    E. Martínez-Bauer. (2006) Prevención de la transmisión nosocomial por el VHC. Gastroenterología y Hepatología 29, 113-116
    CrossRef

  53. 53

    Zvi Fireman. (2006) Biopsy forceps: Reusable or disposable?. Journal of Gastroenterology and Hepatology 21:7, 1089-1092
    CrossRef

  54. 54

    Linda Bisset, Yvonne E. Cossart, Warwick Selby, Richard West, Denise Catterson, Kate O'Hara, Karen Vickery. (2006) A prospective study of the efficacy of routine decontamination for gastrointestinal endoscopes and the risk factors for failure. American Journal of Infection Control 34:5, 274-280
    CrossRef

  55. 55

    Z. Kadi, P. Saint-Laurent, J.F. Cadranel, C. Joly, P. Dumouchel, S. Jeanne, V. Thiers, O. Ciurana, P. Astagneau. (2006) Retrospective investigation of patients exposed to possible transmission of hepatitis C virus by a capillary blood glucose meter. Journal of Hospital Infection 63:1, 65-69
    CrossRef

  56. 56

    J. Morris, G.J. Duckworth, G.L. Ridgway. (2006) Gastrointestinal endoscopy decontamination failure and the risk of transmission of blood-borne viruses: a review. Journal of Hospital Infection 63:1, 1-13
    CrossRef

  57. 57

    Çetin Karaca, Yilmaz Çakaloğlu, Kadir Demir, Sadakat Özdil, Sabahattin Kaymakoğlu, Selim Badur, Atilla Ökten. (2006) Risk Factors for the Transmission of Hepatitis C Virus Infection in the Turkish Population. Digestive Diseases and Sciences 51:2, 365-369
    CrossRef

  58. 58

    Keith Nemergut, Edward C. Littlewood. 2006. Liver Diseases. , 151-201.
    CrossRef

  59. 59

    Philippe Vanhems, Angele Gayet‐Ageron, Thierry Ponchon, Claude Bernet, Jean‐Alain Chayvialle, Christine Chemorin, Leone Morandat, Marie‐Ange Bibollet, Philippe Chevallier, Jacques Ritter, Jacques Fabry. (2006) Follow‐up and Management of Patients Exposed to a Flawed Automated Endoscope Washer‐Disinfector in a Digestive Diseases Unit • . Infection Control and Hospital Epidemiology 27:1, 89-92
    CrossRef

  60. 60

    J.M. Bayas, M. Bruguera. (2005) Cómo combatir la transmisión nosocomial de la hepatitis C. Gastroenterología y Hepatología 28, 8-14
    CrossRef

  61. 61

    Catherine Dumartin. (2005) Mesures à prendre en cas de contamination d’un patient lors d’une endoscopic digestive. Acta Endoscopica 35:S2, 564-565
    CrossRef

  62. 62

    Bertrand Napoléon, Raymond Lefèvre, Catherine Chapuis, Catherine Chapuis. (2005) Une contamination per-coloscopique par le virus de l’hépatite C : réponse de la SFED. Gastroentérologie Clinique et Biologique 29:10, 1069-1070
    CrossRef

  63. 63

    Jeanne‐Marie Germain, Anne Carbonne, Valerie Thiers, Helene Gros, Sylvie Chastan, Elisabeth Bouvet, Pascal Astagneau. (2005) Patient‐to‐Patient Transmission of Hepatitis C Virus Through the Use of Multidose Vials During General Anesthesia • . Infection Control and Hospital Epidemiology 26:9, 789-792
    CrossRef

  64. 64

    Annunziata Faustini, Maria R. Capobianchi, Mauro Martinelli, Isabella Abbate, Giuseppina Cappiello, Carlo A. Perucci. (2005) A Cluster of Hepatitis C Virus Infections Associated With Ozone‐Enriched Transfusion of Autologous Blood in Rome, Italy • . Infection Control and Hospital Epidemiology 26:9, 762-767
    CrossRef

  65. 65

    B. Zühlsdorf, G. Kampf, H. Floss, H. Martiny. (2005) Suitability of the German test method for cleaning efficacy in washer–disinfectors for flexible endoscopes according to prEN ISO 15883. Journal of Hospital Infection 61:1, 46-52
    CrossRef

  66. 66

    Christiane Gérard, Jean Delwaide, Dolores Vaira, Boris Bastens, Benoît Servais, Etienne Wain, Christian Bataille, Guy Daenen, Jacques Belaïche, . (2005) Evolution over a 10 year period of the epidemiological profile of 1,726 newly diagnosed HCV patients in Belgium. Journal of Medical Virology 76:4, 503-510
    CrossRef

  67. 67

    TAKASHI ISHIKAWA, YASUSHI FUKUSHIMA, YUJIRO SHIOBARA, TSUYOSHI KISHIMOTO, SAKIKO TANNO, IKUO SHOJI, TETSURO SUZUKI, TAMANO MATSUI, YASUSHI SHIMADA, TAKAAKI OHYAMA, RYOZO NAGAI, TATSUO MIYAMURA. (2005) Outbreak of hepatitis C virus infection in an outpatient clinic. Journal of Gastroenterology and Hepatology 20:7, 1087-1093
    CrossRef

  68. 68

    MC Ferreiro, PD Dios, C Scully. (2005) Transmission of hepatitis C virus by saliva?. Oral Diseases 11:4, 230-235
    CrossRef

  69. 69

    Victor de Ldinghen, Pascale Trimoulet, Graldine Cazajous, Pierre-Henri Bernard, Marie-Hlne Schrive, Juliette Foucher, Muriel Faure, Laurent Castra, Julien Vergniol, Michel Amouretti, Herv Fleury, Patrice Couzigou. (2005) Epidemiological and phylogenetic evidence for patient-to-patient hepatitis C virus transmission during sclerotherapy of varicose veins. Journal of Medical Virology 76:2, 279-284
    CrossRef

  70. 70

    Peter C. Obee, Chris J. Griffith, Rose A. Cooper, Richard P. Cooke, Nerys E. Bennion, Michael Lewis. (2005) Real-time monitoring in managing the decontamination of flexible gastrointestinal endoscopes. American Journal of Infection Control 33:4, 202-206
    CrossRef

  71. 71

    B. Zühlsdorf, H. Martiny. (2005) Intralaboratory reproducibility of the German test method of prEN ISO 15883-1 for determination of the cleaning efficacy of washer–disinfectors for flexible endoscopes. Journal of Hospital Infection 59:4, 286-291
    CrossRef

  72. 72

    Xavier Forns, Eva Martnez-Bauer, Anna Feliu, Montserrat Garca-Retortillo, Marta Martn, Eugeni Gay, Miquel Navasa, Jose Mara Snchez-Tapias, Miquel Bruguera, Juan Rods. (2005) Nosocomial transmission of HCV in the liver unit of a tertiary care center. Hepatology 41:1, 115-122
    CrossRef

  73. 73

    S. Chlabicz, A. Grzeszczuk, D. Prokopowicz. (2004) Medical procedures and the risk of iatrogenic hepatitis C infection: case-controlled study in north-eastern Poland. Journal of Hospital Infection 58:3, 204-209
    CrossRef

  74. 74

    Jiaren Sun, Kui Li, Mohamed Tarek Shata, Teh-sheng Chan. (2004) The immunologic basis for hepatitis C infection. Current Opinion in Gastroenterology 20:6, 598-602
    CrossRef

  75. 75

    Frédéric Prat, Jean-François Spieler, Sabine Paci, Coralie Pallier, Jacques Fritsch, André Daniel Choury, Gilles Pelletier, Sylvie Raspaud, Patrice Nordmann, Catherine Buffet. (2004) Reliability, cost-effectiveness, and safety of reuse of ancillary devices for ERCP. Gastrointestinal Endoscopy 60:2, 246-252
    CrossRef

  76. 76

    Lawrence F Muscarella. (2004) Infection control and its application to the administration of intravenous medications during gastrointestinal endoscopy. American Journal of Infection Control 32:5, 282-286
    CrossRef

  77. 77

    JUN HAENG LEE, POONG-LYUL RHEE, JEONG HWAN KIM, JAE J KIM, SEUNG WOON PAIK, JONG CHUL RHEE, JAE-HOON SONG, JOON SUP YEOM, NAM YONG LEE. (2004) Efficacy of electrolyzed acid water in reprocessing patient-used flexible upper endoscopes: Comparison with 2% alkaline glutaraldehyde. Journal of Gastroenterology and Hepatology 19:8, 897-903
    CrossRef

  78. 78

    D. Coskun, J. Aytac, S. Deveci, E. Sonmez. (2004) Evaluation of Surgical‐Site Infections Following Cardiovascular Surgery • . Infection Control and Hospital Epidemiology 25:6, 451-453
    CrossRef

  79. 79

    C. Souvignet, G. Frebourg, L. Baril. (2004) Identifying Patients With Severe Hospital‐Acquired Infections Due to Staphylococcus aureus by Using the Healthcare Cost and Utilization Project (HCUP): Problems and Pitfalls • . Infection Control and Hospital Epidemiology 25:6, 450-451
    CrossRef

  80. 80

    L. F. Muscarella. (2004) Is Gastrointestinal Endoscopy a Risk Factor for Whipple's Disease? • . Infection Control and Hospital Epidemiology 25:6, 453-455
    CrossRef

  81. 81

    Douglas B. Nelson, William R. Jarvis, William A. Rutala, Amy E. Foxx-Orenstein, Gerald Isenberg, Georgia P. Dash, Carla J. Alvarado, Marilee Ball, Joyce Griffin-Sobel, Carol Petersen, Kay A. Ball, Jerry Henderson, Rachel L. Stricof. (2004) Multi-society Guideline for Reprocessing Flexible Gastrointestinal Endoscopes. Diseases of the Colon & Rectum 47:4, 413-421
    CrossRef

  82. 82

    W.A Rutala, D.J Weber. (2004) Reprocessing endoscopes: United States perspective. Journal of Hospital Infection 56, 27-39
    CrossRef

  83. 83

    Arjun Srinivasan. (2003) Epidemiology and prevention of infections related to endoscopy. Current Infectious Disease Reports 5:6, 467-472
    CrossRef

  84. 84

    Douglas B. Nelson, William R. Jarvis, William A. Rutala, Amy E. Foxx‐Orenstein, Gerald Isenberg, Georgia P. Dash, Carla J. Alvarado, Marilee Ball, Joyce Griffin‐Sobel, Carol Petersen, Kay A. Ball, Jerry Henderson, Rachel L. Stricof. (2003) Multi‐society Guideline for Reprocessing Flexible Gastrointestinal Endoscopes • . Infection Control and Hospital Epidemiology 24:7, 532-537
    CrossRef

  85. 85

    K Sandres-Sauné, P Deny, C Pasquier, V Thibaut, G Duverlie, J Izopet. (2003) Determining hepatitis C genotype by analyzing the sequence of the NS5b region. Journal of Virological Methods 109:2, 187-193
    CrossRef

  86. 86

    G. F. Tallis, G. M. Ryan, S. B. Lambert, D. S. Bowden, R. McCaw, C. J. Birch, M. Moloney, J. A. Carnie, S. A. Locarnini, G. J. Rouch, M. G. Catton. (2003) Evidence of patient-to-patient transmission of hepatitis C virus through contaminated intravenous anaesthetic ampoules. Journal of Viral Hepatitis 10:3, 234-239
    CrossRef

  87. 87

    Michelle V. Lisgaris. (2003) The occurrence and prevention of infections associated with gastrointestinal endoscopy. Current Infectious Disease Reports 5:2, 108-113
    CrossRef

  88. 88

    Gerard Krause, Mary Jo Trepka, Robert S. Whisenhunt, Dolly Katz, Omana Nainan, Steven T. Wiersma, Richard S. Hopkins. (2003) Nosocomial Transmission of Hepatitis C Virus Associated With the Use of Multidose Saline Vials • . Infection Control and Hospital Epidemiology 24:2, 122-127
    CrossRef

  89. 89

    Yukihiro Sakurai, Masami Nakatsu, Yuko Sato, Kinuko Sato. (2003) ENDOSCOPE CONTAMINATION FROM HBV- AND HCV-POSITIVE PATIENTS AND EVALUATION OF A CLEANING/DISINFECTING METHOD USING STRONGLY ACIDIC ELECTROLYZED WATER. Digestive Endoscopy 15:1, 19-24
    CrossRef

  90. 90

    B. Zühlsdorf, M. Emmrich, H. Floss, H. Martiny. (2002) Cleaning efficacy of nine different cleaners in a washer–disinfector designed for flexible endoscopes. Journal of Hospital Infection 52:3, 206-211
    CrossRef

  91. 91

    W. Ray Kim. (2002) Global epidemiology and burden of hepatitis C. Microbes and Infection 4:12, 1219-1225
    CrossRef

  92. 92

    Daniele Accapezzato, Francesca Fravolini, Marco Antonio Casciaro, Marino Paroli. (2002) Hepatitis C flare due to superinfection by genotype 4 in an HCV genotype 1b chronic carrier. European Journal of Gastroenterology & Hepatology 14:8, 879-881
    CrossRef

  93. 93

    Bryce Larke, Yu-Wen Hu, Mel Krajden, Vito Scalia, Sean K. Byrne, Lesia R. Boychuk, Judith Klein. (2002) Acute nosocomial HCV infection detected by NAT of a regular blood donor. Transfusion 42:6, 759-765
    CrossRef

  94. 94

    Robin Riley, Christine Beanland, Henk Bos. (2002) Establishing the Shelf Life of Flexible Colonoscopes. Gastroenterology Nursing 25:3, 114-119
    CrossRef

  95. 95

    Michelle J. Alfa, Nancy Olson, Pat DeGagne, Michele Jackson. (2002) A Survey of Reprocessing Methods, Residual Viable Bioburden, and Soil Levels in Patient‐Ready Endoscopic Retrograde Choliangiopancreatography Duodenoscopes Used in Canadian Centers • . Infection Control and Hospital Epidemiology 23:4, 198-206
    CrossRef

  96. 96

    Balakrishnan S Ramakrishna. (2002) Safety of technology: Infection control standards in endoscopy. Journal of Gastroenterology and Hepatology 17:4, 361-368
    CrossRef

  97. 97

    John M. Embil, George G. Zhanel, Pierre J. Plourde, Daryl Hoban. (2002) Scissors: A Potential Source of Nosocomial Infection • . Infection Control and Hospital Epidemiology 23:3, 147-151
    CrossRef

  98. 98

    M. Bourliere, J. M. Barberin, M. Rotily, V. Guagliardo, I. Portal, L. Lecomte, S. Benali, C. Boustiere, H. Perrier, M. Jullien, G. Lambot, R. Loyer, O. LeBars, R. Daniel, H. Khiri, P. Halfon. (2002) Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. Journal of Viral Hepatitis 9:1, 62-70
    CrossRef

  99. 99

    ngela Domnguez, Miquel Bruguera, Josep Vidal, Pere Plans, Llus Salleras. (2001) Community-based seroepidemiological survey of HCV infection in Catalonia, Spain. Journal of Medical Virology 65:4, 688-693
    CrossRef

  100. 100

    E. Bilikova, J. Hanzen, , M. Liskova, A. Roidova, V. Krcmery. (2001) Enterococcal Bacteremia in Cancer Patients • . Infection Control and Hospital Epidemiology 22:11, 668-668
    CrossRef

  101. 101

    Jean‐Claude Desenclos, Martine Bourdiol‐Razes, Bernard Rolin, Patrick Garandeau, Jacques Ducos, Christian Brechot, Valerie Thiers. (2001) Hepatitis C in a Ward for Cystic Fibrosis and Diabetic Patients: Possible Transmission by Spring‐Loaded Finger‐Stick Devices for Self‐Monitoring of Capillary Blood Glucose • . Infection Control and Hospital Epidemiology 22:11, 701-707
    CrossRef

  102. 102

    L. F. Muscarella. (2001) Recommendations for Preventing Hepatitis C Virus Infection: Analysis of a Brooklyn Endoscopy Clinic's Outbreak • . Infection Control and Hospital Epidemiology 22:11, 669-669
    CrossRef

  103. 103

    R.N. Charrel, R. de Chesse, A. Decaudin, P. De Micco, X. de Lamballerie. (2001) Evaluation of disinfectant efficacy against hepatitis C virus using a RT-PCR-based method. Journal of Hospital Infection 49:2, 129-134
    CrossRef

  104. 104

    P. Björkman, A. Nauclér, N. Winqvist, I. Mushahwar, A. Widell. (2001) A case-control study of transmission routes for GB virus C/hepatitis G virus in Swedish blood donors lacking markers for hepatitis C virus infection. Vox Sanguinis 81:3, 148-153
    CrossRef

  105. 105

    Peter Heeg, Klaus Roth, Rudolf Reichl, C. Philip Cogdill, Walter W. Bond. (2001) Decontaminated Single‐Use Devices: An Oxymoron That May Be Placing Patients at Risk for Cross‐contamination • . Infection Control and Hospital Epidemiology 22:9, 542-549
    CrossRef

  106. 106

    H. Martiny, H. Floss. (2001) Residuals on medical devices following reprocessing. Journal of Hospital Infection 48, S88-S92
    CrossRef

  107. 107

    J. Steinmann. (2001) Some principles of virucidal testing. Journal of Hospital Infection 48, S15-S17
    CrossRef

  108. 108

    Lauer, Georg M., Walker, Bruce D., . (2001) Hepatitis C Virus Infection. New England Journal of Medicine 345:1, 41-52
    Full Text

  109. 109

    Amy Beth Kressel, Francine Kidd. (2001) Pseudo‐Outbreak of Mycobacterium chelonae and Methylobacterium mesophilicum Caused by Contamination of an Automated Endoscopy Washer • . Infection Control and Hospital Epidemiology 22:7, 414-418
    CrossRef

  110. 110

    Claudia C.Trasancos, Marion A. Kainer, Paul V. Desmond, Heath Kelly. (2001) Investigation of potential iatrogenic transmission of hepatitis C in Victoria, Australia. Australian and New Zealand Journal of Public Health 25:3, 241-244
    CrossRef

  111. 111

    David J. Weber, William A. Rutala. (2001) The Emerging Nosocomial Pathogens Cryptosporidium, Escherichia coli O157:H7, Helicobacter pylori , and Hepatitis C: Epidemiology, Environmental Survival, Efficacy of Disinfection, and Control Measures • . Infection Control and Hospital Epidemiology 22:5, 306-315
    CrossRef

  112. 112

    Lawrence F. Muscarella. (2001) Biopsy Forceps: Disposable or Reusable?. Gastroenterology Nursing 24:2, 64-68
    CrossRef

  113. 113

    Antje Knöll, Magdalena Helmig, Ove Peters, Wolfgang Jilg. (2001) Hepatitis C Virus Transmission in a Pediatric Oncology Ward: Analysis of an Outbreak and Review of the Literature. Laboratory Investigation 81:3, 251-262
    CrossRef

  114. 114

    Alexander C Haushofer, Camel Kopty, Rene Hauer, Harald Brunner, Walter-Michael Halbmayer. (2001) HCV genotypes and age distribution in patients of Vienna and surrounding areas. Journal of Clinical Virology 20:1-2, 41-47
    CrossRef

  115. 115

    R. Systchenko. (2000) Recommandations pour la mise en place de procédures de nettoyage et de désinfection en endoscopie digestive. Acta Endoscopica 30:S2, 329-339
    CrossRef

  116. 116

    Joseph W Leung. (2000) Reprocessing of flexible endoscopes. Journal of Gastroenterology and Hepatology 15:s3, G73-G77
    CrossRef

  117. 117

    Kazuei Ogoshi, Taiji Akamatsu, Hiroyasu Iishi, Daizo Saito, Nobuhiro Sakaki, Chihiro Sekiya, Akira Matsuura, Kenichi Fujita, Tatsuzo Kasugai. (2000) B. Infection in Gastrointestinal Endoscopy. Digestive Endoscopy 12:4, 371-373
    CrossRef

  118. 118

    Catherine Petruff Cheney, Sanjiv Chopra, Camilla Graham. (2000) HEPATITIS C. Infectious Disease Clinics of North America 14:3, 633-667
    CrossRef

  119. 119

    Hugo Sax, Didier Pittet. (2000) Disinfectants that do. Current Opinion in Infectious Diseases 13:4, 395-399
    CrossRef

  120. 120

    Diane Franchi, Ashkan Bahrani, Janis F. Ober, Michael B. Edmond. (2000) Preventing nosocomial infections from gastrointestinal endoscopy. Current Gastroenterology Reports 2:4, 294-298
    CrossRef

  121. 121

    &NA;. (2000) Guideline for the Use of High-Level Disinfectants and Sterilants for Reprocessing of Flexible Gastrointestinal Endoscopes. Gastroenterology Nursing 23:4, 180-187
    CrossRef

  122. 122

    Ph. Hartemann. (2000) Endoscopie — SIDA et désinfection. Acta Endoscopica 30:3, 205-210
    CrossRef

  123. 123

    Carla J. Alvarado, Mark Reichelderfer. (2000) APIC guideline for infection prevention and control in flexible endoscopy. American Journal of Infection Control 28:2, 138-155
    CrossRef

  124. 124

    Hugo R. Rosen. (2000) Primer on Hepatitis C for Hospital Epidemiologists • . Infection Control and Hospital Epidemiology 21:3, 229-234
    CrossRef

  125. 125

    Susan J. Gordon. (2000) Reusable versus disposable forceps: the dilemma of cost and safety. Gastrointestinal Endoscopy 51:3, 363-365
    CrossRef

  126. 126

    John Rizzo, David Bernstein, Frank Gress. (2000) A performance, safety and cost comparison of reusable and disposable endoscopic biopsy forceps: a prospective, randomized trial. Gastrointestinal Endoscopy 51:3, 257-261
    CrossRef

  127. 127

    Pierre H. Deprez, Yves Horsmans, Marc Van Hassel, Pierre Hoang, Hubert Piessevaux, André Geubel. (2000) Disposable versus reusable biopsy forceps: a prospective cost evaluation. Gastrointestinal Endoscopy 51:3, 262-265
    CrossRef

  128. 128

    Russell Yang, Serena Ng, Michael Nichol, Loren Laine. (2000) A cost and performance evaluation of disposable and reusable biopsy forceps in GI endoscopy. Gastrointestinal Endoscopy 51:3, 266-270
    CrossRef

  129. 129

    W.A. Rutala, D.J. Weber. (1999) Infection control: the role of disinfection and sterilization. Journal of Hospital Infection 43, S43-S55
    CrossRef

  130. 130

    Bret T. Petersen. (1999) Gaining perspective on reprocessing of GI endoscopes. Gastrointestinal Endoscopy 50:2, 287-291
    CrossRef

  131. 131

    Bruno Chanzy, Dominique Luu Duc-Bin, Béatrice Rousset, Patrice Morand, Christine Morel-Baccard, Bernard Marchetti, Jérome Fauconnier, Marie-Reine Mallaret, Jean Calop, Jean-Pierre Zarski, Jean-Marie Seigneurin. (1999) Effectiveness of a manual disinfection procedure in eliminating hepatitis C virus from experimentally contaminated endoscopes. Gastrointestinal Endoscopy 50:2, 147-151
    CrossRef

  132. 132

    KM Roy, J. Bagg. (1999) Hepatitis C virus and oral disease: a critical review. Oral Diseases 5:4, 270-277
    CrossRef

  133. 133

    Catherine Sartor, Remi Nicolas Charrel, Xavier de Lamballerie, Roland Sambuc, Philippe De Micco, Leon Boubli. (1999) Evaluation of a Disinfection Procedure for Hysteroscopes Contaminated by Hepatitis C Virus • . Infection Control and Hospital Epidemiology 20:6, 434-436
    CrossRef

  134. 134

    Jean-François Rey. (1999) Endoscopic Disinfection. Journal of Clinical Gastroenterology 28:4, 291-297
    CrossRef

  135. 135

    (1999) Guideline for the Use of High-Level Disinfectants and Sterilants for Reprocessing of Flexible Gastrointestinal Endoscopes. Gastroenterology Nursing 22:3, 127-134
    CrossRef

  136. 136

    Richard A. KOZAREK. (1999) Endoscope and Accessory Reprocessing. Digestive Endoscopy 11:2, 103-107
    CrossRef

  137. 137

    William A. Rutala, David J. Weber. (1999) Disinfection of Endoscopes: Review of New Chemical Sterilants Used for High‐Level Disinfection • . Infection Control and Hospital Epidemiology 20:1, 69-76
    CrossRef

  138. 138

    J. D elwaide, C. G erard, D. V aira, G. M aggipinto, B. R entier, J. B elaiche. (1999) Letter to the Editor. Journal of Internal Medicine 245:1, 107-108
    CrossRef

  139. 139

    Rome Jutabha, Dennis M. Jensen, Gustavo Machicado, Ken Hirabayashi. (1998) Randomized controlled studies of Injection Gold Probes compared with monotherapies for hemostasis of bleeding canine gastric ulcers. Gastrointestinal Endoscopy 48:6, 598-605
    CrossRef

  140. 140

    Jean-François REY, Thierry PONCHON. (1998) Prevention of Endoscopic Risk of Type C Hepatitis and Creutzfeldt Jakob Disease Transmission. Digestive Endoscopy 10:3, 191-194
    CrossRef

  141. 141

    F. Ebeling. (1998) Epidemiology of the Hepatitis C Virus. Vox Sanguinis 74:S2, 143-146
    CrossRef

  142. 142

    Michel Jadoul. (1998) Hepatitis C. The Lancet 351:9110, 1209
    CrossRef

  143. 143

    Miriam J. Alter, Eric E. Mast, Linda A. Moyer, Harold S. Margolis. (1998) HEPATITIS C. Infectious Disease Clinics of North America 12:1, 13-26
    CrossRef

  144. 144

    (1997) Transmission of Hepatitis C Virus during Colonoscopy. New England Journal of Medicine 337:25, 1848-1849
    Full Text

  145. 145

    Jf. Rey, X. Roblin. (1997) Hepatite C: Encore L’endoscopie Digestive. Acta Endoscopica 27:3, 265-265
    CrossRef

Letters